The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Adults who developed severe obesity before the age of 18 are nearly three times more likely than those who developed the ...

Currently, more than 42% of adults in the United States have obesity. Among young people, about 1 in 5 adolescents are also ...

New UK research reveals that obesity significantly worsens pain, mobility, and daily functioning in older adults with knee ...

Obesity and poor diet quality are major issues among adults with severe mental illness, and current weight management ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...

Nationally representative survey data reveals that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) use for obesity treatment more than tripled among US adults without diabetes between 2018 and ...

In an internal memo, the World Health Organization signaled its support for anti-obesity drugs like Wegovy and Zepbound, ...

Adults with overweight or obesity plus prediabetes maintain most of their weight loss with tirzepatide at more than 3 years, according to data from two European Congress on Obesity abstracts.

This marks a shift in the agency's approach to treating the global obesity problem. Read more at straitstimes.com. Read more ...

Cancer cases are increasing in adolescents and young adults, while three types of cancers are on the rise for women, per a ...